Takeda: Global Plasma Alliance in the fight against COVID-19

Monday, 27 April 2020 03:51 Written by 

World-leading plasma companies collaborate to accelerate the development of a potential COVID-19 hyperimmune therapy.

Takeda has been working intensively on the development of a potential plasma-derived therapy for the treatment of COVID-19 since the beginning of the corona crisis. At the beginning of April, Takeda Pharmaceutical Company Limited and CSL Behring announced the establishment of a global plasma alliance to accelerate the development of a potential therapy to treat people with serious complications from COVID-19. Four other plasma companies have already joined the alliance, such as Biotest, BPL, LFB, and Octapharma.

“Unprecedented times call for bold moves,” said Julie Kim, President of Plasma-Derived Therapies Business Unit, Takeda. “We collectively agree that by collaborating and bringing industry resources together, we could accelerate bringing a potential therapy to market as well as increase the potential supply. We invite companies and institutions focusing on plasma to support or join our alliance.”

Thomas R. Kreil, Head of Global Pathogen Safety at Takeda explains: “The Takeda manufacturing site in Vienna has a 65-year history in the development and production of plasma-derived therapies from which we now benefit for the development of a possible therapy. The global alliance of leading plasma companies to develop a treatment for COVID-19 is an important step. It is no longer a question of who comes first to the market, but that everyone, together, increases the pace, bundles experience and efforts, and that larger amounts of treatment become available. The result will be a drug that belongs to everyone.”

Developing a hyperimmune requires plasma donations from many individuals who have fully recovered from COVID-19, and whose blood contains antibodies that can fight the novel coronavirus. Once collected, the “convalescent” plasma would then be transported to manufacturing facilities where it undergoes proprietary processing, including effective virus inactivation and removal processes, and then is purified into the product.

 

How to become a COVID-19 lifesaver in Austria

If you have fully recovered from COVID-19 call +43 (0) 120 609 2538 or send an email to This email address is being protected from spambots. You need JavaScript enabled to view it. and make an appointment for a plasma donation in one of our Takeda plasma centers in Austria, called BioLife. Feel free to share this information within your network and get more details on www.plasmaspende.at.

 

Plasma donation is a safe process and more important than ever for patients in times of COVID-19

Donating plasma is a very safe process. Due to the current situation, the security measures in our BioLife centers in Austria have been tightened again – among other things, through additional and comprehensive hygiene and disinfection measures and the increase in social distancing in the waiting and reception area as well as in the dispenser room. The safety of donors our top priority. Despite the current restrictions in public life, plasma donations are permitted and are also clearly supported by the authorities in Austria.

Anyone can come into a situation where the administration of a plasma-based therapy becomes necessary. This can be, for example, in the context of a medical emergency, such as an accident, during an operation or after severe burns. This is made possible by the so-called fibrin glue, which can be used, among other things, for tissue bonding, hemostasis and to promote wound healing. Blood plasma also helps patients who are dependent on plasma-derived products due to an immune disorder, such as an immune deficiency or rare disease. These people often have a weakened immune system and belong to the risk group of COVID-19. It is more important than ever that they continue to receive their therapies, and everyone can contribute to this by donating plasma.

 

About Takeda in Austria

Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines.

The facilities of Takeda in Austria have a long history. What began in 1778 is today a the largest pharmaceutical employer in Austria and thus an important part of the domestic pharmaceutical industry. Takeda Austria serves the entire value chain: from Research & Development, sourcing human blood plasma in twelve plasma centers in Austria, through the production of medicines from human plasma and recombinant products, to the worldwide shipping of finished products. The domestic research and production facilities are located in Vienna, Linz and Orth an der Donau.

Everyday, round 4,500 employees contribute to bringing medicines from Austria to more than 100 countries worldwide and giving people in Austria access to Takeda's innovative medicines. The product portfolio helps Austrian patients in areas such as oncology, gastroenterology, immunology, hemophilia and genetic diseases. Learn more about Takeda in Austria.

 

Manufacturing in Vienna   Manufacturing Vienna1   Manufacturing Vienna6

Published in Mitgliedsnews
  • FEMS - Get Involved bulletin – December 2020
    The FEMS Get involved bulletin is out! Read the December issue with microbiology research, events and calls. In this bulletin: World Microbe Forum Call for ECS as reviewers for FEMS Microbes FEMS Online 2020 Scientists Interviews Poster prize winners interviews Conference on demand International Microorganism Day video series Call for papers Meet our FEMS Ambassador for Canada Meet our Research and Training Grantee Meet our Research and Attendance Grantee Grant application…
    08.01.2021,
  • FEMS Affiliates Letter - Dezember 2020
    As member of the ÖGMBT you are automatically also member of the Federation of European Microbiology Societies (FEMS). The FEMS Affiliates Letter of December 2020 has the following content: Page 2-3: Microbiology News Page 4-7: New Research in the FEMS Journals Page 8-9: Grants Corner, Events & Opportunities Page 10: Deadlines, Videos & Extras  
    04.01.2021,
  • FEMS Affiliates Letter - November 2020
    As member of the ÖGMBT you are automatically also member of the Federation of European Microbiology Societies (FEMS). The FEMS Affiliates Letter of November 2020 has the following content: Page 2-3: Microbiology News Page 4-7: New Research in the FEMS Journals Page 8-9: Grants Corner, Events & Opportunities Page 10: Deadlines, Videos & Extras
    02.12.2020,
  • FEMS - Get Involved bulletin – November 2020
    The FEMS Get involved bulletin is out! Read the November issue with microbiology research, events and calls. Some highlights: Call for Early Career Scientists as FEMS Microbes reviewers Join the FEMS grants committee Grant application deadlines Meet FEMS Research & Training grantee Alexandra Veress World Antimicrobial Awareness Week Antibiotic resistance symbol FEMS Journals prize winners Webinars Job opportunities   The ÖGMBT has a very wide international network and is a…
    02.12.2020,
  • That was the kick off of Austria's 1st Life Science Career Fair
    In these exciting times it is a special challenge but also a pleasure to create something new. We were immediately thrilled when Alexandra Khassidov,  o the managing director of our cooperation partner of the Austrian Association of Molecular Life Sciences and Biotechnology (ÖGMBT) contacted us with the idea of an Austria-wide life science career fair. A joint organization was quickly decided on, whereupon Life Science Austria (LISA) and other Austrian…
    02.11.2020,
  • FEMS - Get Involved bulletin – October 2020
    The FEMS Get involved bulletin is out! Read the October issue with microbiology research, events and calls. Some highlights: Call for Early Career Scientists as Reviewers for FEMS Microbes FEMS Webinars FEMS Microbes Research Poster Prize World Antimicrobial Awareness Week Top 3 Opportunities this month Grant Application Deadlines The ÖGMBT has a very wide international network and is a member of several relevant scientific societies like FEMS. ÖGMBT members are…
    02.11.2020,
  • FEMS Affiliates Letter - October 2020
    As member of the ÖGMBT you are automatically also member of the Federation of European Microbiology Societies (FEMS). The FEMS Affiliates Letter of October 2020 has the following content: Page 2-3: FEMS Microbiology News Page 4-7: New Research in the FEMS Journals Page 8-9: Grants Corner, Events & Opportunities Page 10: Deadlines, Videos & Extras See ÖGMBT Special - Page 9: Life Science Tuesday #5: Microbiome Innovations
    29.10.2020,
  • Life Science Tuesday #2/12 – “RNA Biology” - October 20 - Program & Abstract Booklet
    FREE REGISTRATION FOR PERSONAL MEMBERS Our first Life Science Tuesday “Lipids and Metabolism” was well attended, the discussions in the breakout rooms were lively, the Short Talks by young talents were on a high standard and we were enthused by the quality and creativity of the Science Flashes. Thanks to all who participated! We expect no less at our next Life Science Tuesday #2/12 dedicated to “RNA Biology” supported by…
    16.10.2020,
  • Posterchallenge Deadline extension 16.10.2020
    Dear colleagues, the Austrian Platform for Personalized Medicine (“Österreichische Plattform für Personalisiere Medizin” ÖPPM) is pleased to invite you to an Austrian-wide competition for students in (e-) health and IT sciences at Universities and Institutions for Applied Sciences during the annual (virtual!) ÖPPM meeting in autumn 2020.   „What means Personalized Medicine and Digitalization for you in your area of expertise?“   10 carefully chosen posters will be presented on…
    12.10.2020,
  • FEMS Affiliates Letter - September 2020
    As member of the ÖGMBT you are automatically also member of the Federation of European Microbiology Societies (FEMS). The FEMS Affiliates Letter of September 2020 has the following content: Page 2-3: FEMS Microbiology News Page 4-5: MicroLife, FEMS Microbes Page 6-7:  New Research in the FEMS Journals Page 8-9: Grants Corner, Events & Opportunities Page 10: Deadlines, Videos & Extras    
    05.10.2020,
  • LISAvienna to publish a new Highlights folder
    Dear Readers,  the new edition of our Highlights folder is in print. We are happy to share the digital version with you and introduce the main topics: - COVID-19: Tests and medicine candidates in the Vienna region - Advancing SARS-CoV-2-related innovation in Austria - Startup Labs at the Vienna BioCenter - MSD completes acquisition of Themis Download the file and enjoy reading https://www.lisavienna.at/fileadmin/user_upload/LISAvienna/Downloads/LISAvienna_Highlights_Fall_Winter_2020.pdf  Johannes Sarx and Philipp Hainzl LISAvienna Executive Board…
    09.12.2020,
  • Safety first
    01.10.2020,
  • EURAXESS Career Orientation tool
    No limits: explore your career as a researcher   The 'No limits' toolkit for researchers highlights resources to help you identify what's important for you in your career plan to build on your skills and knowledge consider a wide range of career options make a plan to reach your professional development goals The toolkit includes advice, quizzes to help you explore your own needs and links to resources, information and…
    24.06.2020,
  • Stipendien und Förderungen
    Österreichs größte Datenbank für Stipendien und Forschungsförderung richtet sich an Incomings und Outgoings. Sie enthält aktuelle Ausschreibungen für Stipendien, Zuschüsse, Forschungsförderungen, Praktika und Forschungspreise. Interessierte können gezielt nach passenden Stipendien und Förderungen suchen. >> www.grants.at
    08.05.2020,
  • Takeda: Global Plasma Alliance in the fight against COVID-19
    World-leading plasma companies collaborate to accelerate the development of a potential COVID-19 hyperimmune therapy. Takeda has been working intensively on the development of a potential plasma-derived therapy for the treatment of COVID-19 since the beginning of the corona crisis. At the beginning of April, Takeda Pharmaceutical Company Limited and CSL Behring announced the establishment of a global plasma alliance to accelerate the development of a potential therapy to treat people…
    27.04.2020,
    by
  • Checklist for conducting virtual meetings
    Most of us are in home office and are experiencing many virtual meetings with various tools like skype, zoom, slack, gotomeeting. Leading teams in real life is a challenge, leading teams virtually even more. Together with Irene, an expert in meeting design and team leading, our staff member Andrea has co-edited a virtual meetings checklist. You can download the checklist for free (in English and German) from Irene’s website.
    09.04.2020,
    by
  • Research funding
    The Corona Crisis has also impacted research funding. Many new opportunities arise and most deadlines for grant applications have been postponed. Here are two: Austrian Government rolls out 23 Mio funds for the research of corona therapy. https://www.ffg.at/ausschreibung/emergencycall-covid-19   Horizon 2020, the EU programme for Research and Innovation, prolongs its’ deadlines for grant-applications https://www.ffg.at/europa/h2020
    08.04.2020,
    by
  • Österreichische Jobbörse für Forschung, Entwicklung und Innovation
    Die österreichische Jobbörse für Forschung, Entwicklung und Innovation Sind Sie auf Jobsuche? Hier finden Sie täglich neue Jobs, vom Praktikum bis zur Top-Position. Rund 2000 offene Stellen warten österreichweit auf Sie. www.ffg.at/jobboerse _________________________________________________________ The Austrian Job Exchange for Research, Development and Innovation Are you looking for a job in Austria? Here you´ll find daily new jobs, from internships to top positions. Around 2,000 vacancies are waiting for you throughout Austria.…
    29.11.2019,
    by
  • Neues FFG-Karriereprogramm in Planung
    Für das Jahr 2020 arbeitet w-fFORTE (Wirtschaftsimpulse von Frauen in Forschung & Technologie) gerade an einem neuen modular aufgebauten Karriere-Format (Trainings, Selbstreflexion, Networking, Projektentwicklung), um Frauen in Forschung & Innovation zu unterstützen, in ihrem beruflichen und persönlichen Wirken weiterzukommen. Beteiligen Sie sich mit Ihren Bedürfnissen & Erfahrungen bei unseren Entwicklungsaktivitäten: Für Forscherinnen & Innovatorinnen: - Online-Umfrage (bis 22.9.) - Teilnahme an der Fokusgruppe im Oktober (Bei Interesse bitte mail an…
    01.10.2019,
  • Einladung FEMtech Netzwerktreffen: Digitalisierung macht alles anders. Auch die Chancengleichheit?
    Montag, 14. Oktober, 2019, 16.00-18.00 Uhr Tech Gate Vienna, Donau-City-Straße 1, 1220 Wien Nadja Bergmann (L&R Sozialforschung) präsentiert die Ergebnisse und Highlights der Studie „Digitalisierung - Industrie 4.0 - Arbeit 4.0 - Gender 4.0“. Sie wird einen Einblick in die gegenwärtige Diskussion geben und die Zukunft der Arbeitswelt vor dem Hintergrund der Gender-Dimension erläutern. Alle Interessierten sind herzlich eingeladen. Die Teilnahme ist kostenlos. Einladung und Anmeldung: https://www.ffg.at/femtech-nwt/digitalisierung #BMVIT #FFG
    01.10.2019,
  • Chief Technology Officer (m/f/d)
    Chief Technology Officer (m/f/d) SAN GroupDer Beitrag Chief Technology Officer (m/f/d) erschien zuerst auf Jobbörse und Netzwerk für Naturwissenschafter /-innen....
    16.01.2021,
  • Labortechniker – Impfstoffe (m/f/d)
    Labortechniker – Impfstoffe (m/f/d) SAN GroupDer Beitrag Labortechniker – Impfstoffe (m/f/d) erschien zuerst auf Jobbörse und Netzwerk für Naturwissenschafter /-innen....
    16.01.2021,
  • Team Member Nonclinical Safety (m/f/d) R&D Accelerator
    Team Member Nonclinical Safety (m/f/d) R&D Accelerator Boehringer Ingelheim RCVDer Beitrag Team Member Nonclinical Safety (m/f/d) R&D Accelerator erschien zuerst auf Jobbörse und Netzwerk für Naturwissenschafter /-innen....
    16.01.2021,
  • Technical Sales Manager (m/f/d)
    Technical Sales Manager (m/f/d) SAN GroupDer Beitrag Technical Sales Manager (m/f/d) erschien zuerst auf Jobbörse und Netzwerk für Naturwissenschafter /-innen....
    16.01.2021,
  • GESCHÄFTSFELDLEITUNG ÖFFENTLICHE GESUNDHEIT
    GESCHÄFTSFELDLEITUNG ÖFFENTLICHE GESUNDHEIT AGES Agentur für Gesundheit und ErnährungssicherheitDer Beitrag GESCHÄFTSFELDLEITUNG ÖFFENTLICHE GESUNDHEIT erschien zuerst auf Jobbörse und Netzwerk für Naturwissenschafter /-innen....
    16.01.2021,
  • Facharzt (m/w/d) für Allgemeinmedizin 30-34 h/Woche
    Facharzt (m/w/d) für Allgemeinmedizin 30-34 h/Woche Peter Grill ÄrztevermittlungDer Beitrag Facharzt (m/w/d) für Allgemeinmedizin 30-34 h/Woche erschien zuerst auf Jobbörse und Netzwerk für Naturwissenschafter /-innen....
    16.01.2021,
  • Assistenzarzt (m/w/d) für Haut- und Geschlechtskrankheiten 40-100%
    Assistenzarzt (m/w/d) für Haut- und Geschlechtskrankheiten 40-100% Peter Grill ÄrztevermittlungDer Beitrag Assistenzarzt (m/w/d) für Haut- und Geschlechtskrankheiten 40-100% erschien zuerst auf Jobbörse und Netzwerk für Naturwissenschafter /-innen....
    16.01.2021,
  • fh-campus-career-event
    boost your future career in life sciencesCareer Event FH Campus WienSection of BiotechnologyTuesday 26th January 3 – 5 pm online via ZoomCongratulations on your decision to study life sciences! As the professional activities of life-scientists range from health to food production, from nutrition to environment protection and bioenergy and more,...
    13.01.2021,
  • FACHEXPERTE/IN AMTLICHER PFLANZENSCHUTZDIENST
    FACHEXPERTE/IN AMTLICHER PFLANZENSCHUTZDIENST AGES Agentur für Gesundheit und ErnährungssicherheitDer Beitrag FACHEXPERTE/IN AMTLICHER PFLANZENSCHUTZDIENST erschien zuerst auf Jobbörse und Netzwerk für Naturwissenschafter /-innen....
    13.01.2021,
  • Compliance ManagerIn für Engineering & Technologies (E&T)
    Compliance ManagerIn für Engineering & Technologies (E&T) Boehringer Ingelheim RCVDer Beitrag Compliance ManagerIn für Engineering & Technologies (E&T) erschien zuerst auf Jobbörse und Netzwerk für Naturwissenschafter /-innen....
    13.01.2021,